SCHEMBL2680940

SCHEMBL2680940

CCC(=O)c1c(N2C=C3C(=O)NC(=O)N3CC2)nc2c(-c3cnc4ccccc4c3)cnn2c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.36
TDP2 O95551 1/20 0.34
FASN P49327 5/20 0.33
AKT1 P31749 2/20 0.33
MTOR P42345 2/20 0.33
BRD4 O60885 2/20 0.33
CREBBP Q92793 2/20 0.33
PARP10 Q53GL7 1/20 0.33
PARP11 Q9NR21 1/20 0.33
DYRK1A Q13627 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
NFKB1 P19838 1/20 0.33
STAT1 P42224 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2686645 0.80 PIK3CA (0.36) PIK3CAFASNAKT1MTORKDM4E
SCHEMBL2680938 0.78 PIK3CA (0.35) PIK3CAFASNAKT1MTORBRD4
SCHEMBL598856 0.76 TDP2 (0.31) TDP2PARP10PARP11
SCHEMBL10280112 0.75 PIK3CA (0.35) PIK3CAFASNAKT1MTORBRD4
SCHEMBL2680939 0.73 PIK3CA (0.37) PIK3CAFASNAKT1MTORBRD4
SCHEMBL2685000 0.71 WNT3A (0.35) PIK3CAMTORKDM4ENPC1ALDH1A1
SCHEMBL6893608 0.71 MAP4K4 (0.38) PIK3CAFASNAKT1MTORNPC1
SCHEMBL584148 0.70 AKR1C3 (0.43) PIK3CAMTORKDM4ENPC1ALDH1A1
SCHEMBL7885236 0.69 PIK3CA (0.36) PIK3CAFASNAKT1MTORBRD4
SCHEMBL7881257 0.68 PIK3CA (0.35) PIK3CAAKT1MTORKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8591943-B2 Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors MERCK SHARP & DOHME CORP. (US) 2013-11-26 US disclosed
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MTOR, RICTOR, RPTOR PIK3CA 34/4885TDP2 2502/4885FASN 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.